Patient‐Led Urate Self‐Monitoring to Improve Clinical Outcomes in People With Gout: A Feasibility Study

Documenti analoghi

• Correction to “Gout Remission With Pegloticase‐Induced Intensive Urate‐Lowering Therapy: A Post Hoc Clinical Trial Analysis”
  Pubblicazione: (2025)
• The Design of a Randomized Controlled Active Comparator Strategy Trial for Gout: Treat to Target Serum Urate Versus Treat to Avoid Symptoms
  di: Daniel H. Solomon, et al.
  Pubblicazione: (2025)
• Firsekibart as a Prophylactic Treatment for Acute Gout Flare in Participants Initiating Urate‐Lowering Therapy: A Phase 2, Randomized, Open‐Label, Multicenter, Active‐Controlled Trial
  di: Yiyun Yu, et al.
  Pubblicazione: (2025)
• Pegloticase and Methotrexate Cotherapy in Patients With Uncontrolled Gout With Prior Pegloticase Monotherapy Failure: Findings of an Open‐Label Trial
  di: Orrin M. Troum, et al.
  Pubblicazione: (2025)
• Impact of Scleroderma‐Associated Autoantibodies on Clinical Outcome Assessments: Post Hoc Analysis From a Randomised, Double‐blind, Placebo‐controlled, Phase 3 Trial of Tocilizumab in Scleroderma
  di: Basmah Al Dulaijan, et al.
  Pubblicazione: (2025)